ACME repositions amid CME shifts
“A new healthcare learning environment has emerged,” Dr. George Mejicano, Alliance president, said in a statement. “Inter-professional education is the new reality.”
Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.
"An epidemic comes and goes. This is a trend curve. We need to bend that curve."
When Monique Levy, one of the most-level-headed analysts in the pharma industry, calls attention to a mysterious phenomenon, you listen.